Arcturus Therapeutics Holdings Inc (ARCT)
27.54
+0.22
(+0.81%)
USD |
NASDAQ |
May 07, 16:00
27.54
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.0714 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.2244 |
September 30, 2022 | 0.4101 |
June 30, 2022 | 0.3677 |
March 31, 2022 | 0.3437 |
December 31, 2021 | 0.2765 |
September 30, 2021 | 0.2347 |
June 30, 2021 | 0.2006 |
March 31, 2021 | 0.1738 |
December 31, 2020 | 0.0381 |
September 30, 2020 | 0.0576 |
June 30, 2020 | 0.1612 |
March 31, 2020 | 0.8849 |
December 31, 2019 | 0.5814 |
Date | Value |
---|---|
September 30, 2019 | 0.279 |
June 30, 2019 | 0.4617 |
March 31, 2019 | 1.565 |
December 31, 2018 | 0.7265 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.0843 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
0.8849
Maximum
Mar 2020
0.2509
Average
0.2244
Median
Dec 2022
Debt to Equity Ratio Benchmarks
AIM ImmunoTech Inc | 0.00 |
Perspective Therapeutics Inc | 0.0229 |
Protalix BioTherapeutics Inc | 0.6033 |
Electromed Inc | 0.00 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 429.40M |
Total Liabilities (Quarterly) | 150.89M |
Shareholders Equity (Quarterly) | 278.51M |
Current Ratio | 4.715 |
Net Debt Paydown Yield | 1.41% |